Biomerica, Inc. (BMRA)

Biomerica Cash Flow Statement

Financials in millions USD. Fiscal year is June - May.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 31, 2025	May 31, 2024	May 31, 2023	May 31, 2022	May 31, 2021
Net Income	-4.97	-5.98	-7.14	-4.53	-7.45
Depreciation & Amortization	0.4	0.37	0.35	0.6	0.38
Loss (Gain) From Sale of Assets	-	-	-	0.05	-
Stock-Based Compensation	0.46	0.84	1.19	1.26	1.35
Provision & Write-off of Bad Debts	0.01	-0.01	0.34	-0.68	0.77
Other Operating Activities	0	-0.21	-0.17	-0.77	1.55
Change in Accounts Receivable	0.21	-0.22	-0.29	1.37	-0.46
Change in Inventory	0.88	-0.12	0.53	1.56	-1.91
Change in Accounts Payable	-0.47	0.25	-0.08	0.39	-0.4
Change in Other Net Operating Assets	-0.37	-0.3	-0.2	0.28	0.91
Operating Cash Flow	-3.84	-5.36	-5.47	-0.48	-5.25
Capital Expenditures	-	-0.05	-0.06	-0.06	-0.14
Sale (Purchase) of Intangibles	-0.04	-0.06	-0.01	-0.11	-0.16
Investing Cash Flow	-0.04	-0.12	-0.08	-0.17	-0.3
Issuance of Common Stock	2.16	-	10.1	2.48	1.28
Other Financing Activities	-0.05	-0.08	-0.71	-0.09	-0.17
Financing Cash Flow	2.11	-0.08	9.39	2.39	1.11
Foreign Exchange Rate Adjustments	-0	0.01	-0.04	-0.03	-0.01
Net Cash Flow	-1.77	-5.55	3.8	1.72	-4.44
Free Cash Flow	-3.84	-5.41	-5.54	-0.54	-5.39
Free Cash Flow Margin	-72.32%	-99.94%	-103.73%	-2.84%	-74.84%
Free Cash Flow Per Share	-1.67	-2.57	-3.13	-0.34	-3.61
Cash Income Tax Paid	0.01	0.04	0.05	0.02	0.03
Levered Free Cash Flow	-1.8	-3.14	-2.65	1.07	-2.45
Unlevered Free Cash Flow	-1.8	-3.14	-2.65	1.07	-2.45
Change in Working Capital	0.26	-0.38	-0.04	3.6	-1.85

Updated May 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q